Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03057379 · ClinicalTrials.gov registry record · NA
HPV IIS Reminder/Recall- New York State
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 30,616
- Enrollment target
NCT03057379 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 30,616 participants.
The verdict
NCT03057379, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 30,616 participants
- Enrollment target
Study Summary
The overarching goal of this study is to evaluate the effectiveness, cost-effectiveness and sustainability of utilizing statewide Immunization Information Systems (IIS) to conduct centralized reminder/recall (R/R) to improve Human Papiloma Virus (HPV) vaccination rates among adolescents ages 11-17.
Interventions
- OTHER Vaccine Reminder Recall
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30,616 participants |
| Start Date | 2017-02-27 |
| Est. Completion | 2019-01-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03057379
The ClinicalTrials.gov registry entry for NCT03057379 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30,616 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vaccine Reminder Recall is the first listed.
NCT03057379 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03057379 about?
NCT03057379 is a clinical study titled "HPV IIS Reminder/Recall- New York State". The overarching goal of this study is to evaluate the effectiveness, cost-effectiveness and sustainability of utilizing statewide Immunization Information Systems (IIS) to conduct centralized reminder/recall (R/R) to improve Human Papiloma Virus (HPV) vaccination rates among adolescents ages 11-17.
What is the current status of trial NCT03057379?
This trial is currently completed. It is a NA study. The enrollment target is 30,616 participants. The study started on 2017-02-27. Estimated completion is 2019-01-17.
What interventions are being tested in trial NCT03057379?
The interventions under investigation include: Vaccine Reminder Recall (OTHER).
Who is sponsoring clinical trial NCT03057379?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.